RHHBY's Itovebi combo wins CHMP backing for PIK3CA-mutated breast cancer, showing strong survival benefits in phase III INAVO120 study....
Zymo Research is a top competitor of MACHEREY-NAGEL. Zymo Research was founded in 1994, and is headquartered in Irvine, California. Like MACHEREY-NAGEL, Zymo Research also competes in the Biotechnology field. Zymo Research generates $10M more revenue vs. MACHEREY-NAGEL.